Although our 2 tumor models would not be sufficient for establishing the specific role of TGF-β-TRAP in treating PDAC liver metastasis, they would be valuable for us to elucidate the potential mechanisms in the TME underlying the heterogeneity of response to TGF-β-TRAP treatment. This evidence concerns the gene TGFB1 and neoplasm.